US2023279050A1PendingUtilityA1

Control of Copolymer Compositions

Assignee: MOMENTA PHARMACEUTICALS INCPriority: Apr 3, 2009Filed: Sep 30, 2022Published: Sep 7, 2023
Est. expiryApr 3, 2029(~2.7 yrs left)· nominal 20-yr term from priority
C07K 5/10C07K 14/001A61P 37/00
77
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

Methods of making copolymers are described.

Claims

exact text as granted — not AI-modified
What is claimed is: 
     
         1 . (canceled) 
     
     
         2 . A method for determining the pyro-glutamate content of a sample of glatiramer acetate, the method comprising:
 digesting a sample of glatiramer acetate with  Pyrococcus furiosus  pyroglutamate aminopeptidase to create an enzymatic hydrolysate; and   subjecting the enzymatic hydrolysate to reverse phase liquid chromatography to detect and measure the amount of pyroglutamate in the enzymatic hydrolysate thereby determining the pyro-glutamate content of the sample of glatiramer acetate.   
     
     
         3 . The method of  claim 2 , wherein the glatiramer acetate has a Mp of 5000- 9000 Da. 
     
     
         4 . A method for preparing glatiramer acetate comprising: comprising: polymerizing N-carboxy anhydrides of L-alanine, benzyl-protected L-glutamic acid, trifluoroacetic acid (TFA) protected L-lysine and L-tyrosine to generate a protected copolymer (Intermediate-1);
 treating the Intermediate-1 with HBr and acetic acid to partially depolymerize the protected copolymer and deprotect benzyl-protected L-glutamic acid thereby generating a partially depolymerized product;   treating the partially depolymerized product with piperidine to deprotect TFA-protected lysines thereby generating glatiramer acetate;   purifying the glatiramer acetate; and 
 measuring the pyro-glutamate content of a sample of the purified glatiramer acetate.

Join the waitlist — get patent alerts

Track US2023279050A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.